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OBJECTIVES: To determine the prognostic role of ortho-
static hypotension for cardiovascular disease (CVD) and
all-cause mortality in elderly people.
DESIGN: Prospective study.
SETTING: Community based.
PARTICIPANTS: Five thousand sixty-four subjects from
the Rotterdam study aged 55 and older.
MEASUREMENTS: Orthostatic hypotension was mea-
sured using a Dinamap automatic blood pressure recorder.
Orthostatic hypotension is defined as a decline in systolic
blood pressure of 20mmHg or more or a decline in diastolic
blood pressure of 10mmHg or more from supine to stand-
ing position at any of three measurements taken 1, 2, and 3
minutes after standing.
RESULTS: At baseline, 901 subjects had orthostatic hypo-
tension. During follow-up, 668 subjects had coronary heart
disease (CHD) (mean follow-up 6.0  3.5 years), and 1,835
subjects died (mean follow-up period 7.8  3.8 years). Or-
thostatic hypotension increased the risk of CHD (hazard
ratio (HR)51.31, 95% confidence interval (CI)51.08–
1.57) and all-cause mortality (HR51.22, 95% CI51.09–
1.36), in models adjusted for age and sex. The risk was
slightly lower after additional adjustment for cardiovascu-
lar risk factors. In analyses stratified for age, the HRs for
all-cause mortality were 1.80 (95% CI 1.25–2.60), 1.13
(0.89–1.42), and 1.27 (95% CI51.11–1.44), in the first,
second, and third tertile of age, respectively.
CONCLUSION: Orthostatic hypotension increases the
risk of CHD and all-cause mortality in elderly people.
The risk of CVD and mortality is strongest in younger and
very old subjects. J Am Geriatr Soc 56:1816–1820, 2008.
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Orthostatic hypotension is common in elderly people
1–4
and is associated with syncope,5,6 falls,7 fractures,
and potential morbidity, leading to functional impairment
and hospitalization.8 Several studies have investigated the
relationship between orthostatic hypotension and cardio-
vascular disease (CVD). Well-designed prospective, popula-
tion-based, large-cohort studies have found that orthostatic
hypotension increases the risk of stroke,9 coronary heart
disease (CHD),10 and mortality11 in middle-aged subjects.
Other studies have investigated the prognostic role of ortho-
static hypotension in elderly people, although the results
have been contradictory3,12–15 or performed in specific cat-
egories of patients.16–18 No previous study has investigated
the relationship between orthostatic hypotension and the
risk of heart failure.
The aim of the present study was to investigate whether
orthostatic hypotension increases the risk of primary CVD
and all-cause mortality in elderly people. The present study
was performed within the framework of the Rotterdam
Study, a large, ongoing, prospective, population-based
study that included subjects aged 55 and older at baseline.
METHODS
Study Population
The Rotterdam Study is a prospective population-based
cohort study comprising 7,983 subjects aged 55 and older
living in Ommoord, a suburb of Rotterdam, the Nether-
lands. The overall aim of the Rotterdam Study is to assess
the occurrence of and risk factors for chronic diseases in
elderly people. The study design and objectives of the Rot-
terdam Study are described elsewhere.19 At baseline, a
trained interviewer visited the 7,983 subjects at home to
complete a computerized questionnaire. Participants visited
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the research center for the baseline examination from
March 1990 to July 1993. During these visits at the research
center, blood pressure measurements were obtained, and
established cardiovascular risk factors were measured. The
Medical Ethics Committee of Erasmus Medical Center ap-
proved the study, and written consent was obtained from all
participants.
Previous CVD and Cardiovascular Risk Factors
A history of CHD, stroke, and heart failure was obtained
through direct questioning and was considered positive
when confirmed according to hospital discharge date
or written information from the subject’s general practitio-
ner, as described previously.20–22 CHD was defined as fatal
or nonfatal myocardial infarction (MI), a percutaneous
transluminal coronary angioplasty, a coronary artery bypass
graft, sudden cardiac death, and death due to ventricular
fibrillation and congestive heart failure. A history of MI was
considered present in case of self-report of MI confirmed by
electrocardiogram or additional clinical information or the
presence of an electrocardiogram characteristic of prior MI.
Information on smoking habits and the use of antihyper-
tensive medication was obtained during the interview.
Smoking was divided into three categories: current, former,
and nonsmokers. Height and weight were measured, and
body mass index (BMI) was computed (kg/m2). Diabetes
mellitus was defined as the use of blood glucose–lowering
medication or a random or postload serum glucose level of
11.1mmol/L or higher.23 Serum total cholesterol and high-
density lipoprotein cholesterol (HDL-C) values were deter-
mined using an automated enzymatic procedure (Boehringer
Mannheim System, Mannheim, Germany). Two seated
blood pressure measurements are obtained at the right bra-
chial artery using a random zero sphygmomanometer. The
mean of two consecutive measurements was used. Hyper-
tension was defined as systolic blood pressure of 140mmHg
or greater, diastolic blood pressure of 90mmHg or higher, or
the use of antihypertensive medication. Orthostatic hypo-
tension was measured using an automatic blood pressure
recorder (Dinamap R, Tampa, FL). The baseline reading
was the mean of two blood pressure measurements on the
right upper arm with the subject in supine position after 5
minutes of rest.Measurements were repeated in the standing
position after 1, 2, and 3 minutes. Orthostatic hypotension
was defined as a decline in systolic blood pressure of
20mmHg or more or a decline in diastolic blood pressure of
10mmHg or more from supine to standing position at any
of the three measurements.
Incident Cardiovascular Events and All-Cause Mortality
Information on fatal and nonfatal cardiovascular outcomes
was obtained through automated linkage with the files from
general practitioners and letters and discharge reports from
medical specialists. When a cardiovascular event was re-
ported, the research assistants collected additional infor-
mation from medical records of the general practitioner
and, in addition, obtained information from the hospital
discharge records or nursing home records, including letters
from medical specialists. For the diagnosis of cardiac
events, two research physicians independently coded all
reported events. In the case of disagreement, a medical
expert (JH) in the field made a decision. In the case of
stroke, two research physicians and an experienced neurol-
ogist coded the events. Codes were assigned according to
the International Classification of Diseases, Tenth Revision
(ICD-10).24 CHDwas defined as the occurrence of a fatal or
nonfatal MI (ICD-10 code I21), a percutaneous translumi-
nal coronary angioplasty, a coronary artery bypass graft,
other form of acute (I24) or chronic ischemic heart disease
(I25), sudden cardiac death (I46 and R96), or death due to
ventricular fibrillation (I49) or congestive heart failure
(I50). ICD-10 codes used for coding stroke were I61, I63,
and I64. Heart failure was determined using a validated
score that is similar to the definition of heart failure of the
European Society of Cardiology.25 Information on vital
status was acquired at regular intervals from the municipal
authorities of Rotterdam. For the present study, follow-up
was completed for stroke and CHD until January 2005
and for heart failure and all-cause mortality until October
2006.
Population for Analysis
Seven thousand nine hundred eighty-three subjects (re-
sponse rate 78%) agreed to participate and were inter-
viewed at home, and 7,129 subjects visited the research
center for physical examinations. Blood pressure measure-
ments in the supine and standing positions were available in
6,455 participants. Subjects with CHD (n5 743), stroke
(n5164), or heart failure (n5194) at baseline and subjects
with missing data on smoking (n5 357), use of antihyper-
tensive medication (n52,191), BMI (n51,073), blood
pressure (n5 975), diabetes mellitus (n5 202), total cho-
lesterol (n5 944), and HDL-C (n5973) were excluded
from the analyses. The number with missing data is over-
lapping, leaving 5,064 subjects available for this analysis.
Data Analysis
The baseline characteristics of the subjects with and with-
out orthostatic hypotension were compared using Student
t-tests for continuous variables and chi-square tests for cat-
egorical variables. A power calculation was performed,
which showed a power of 96% to reach a hazard ratio (HR)
of 2 in a population of 5,064 subjects. Cox-proportional
hazard models were used to estimate HRs with correspond-
ing 95% confidence intervals (CIs) for CHD, stroke, heart
failure, and all-cause mortality according to orthostatic hy-
potension status. The first model was adjusted for age and
sex. Model 2 was additionally adjusted for smoking, use of
antihypertensive medication, BMI, systolic blood pressure,
diastolic blood pressure, diabetes mellitus, total cholesterol,
and HDL-C. To investigate whether the prognostic role of
orthostatic hypotension varied with aging together with the
age-related changes of cardiovascular risk load, analyses
were performed in tertiles of age, sex, hypertension status,
and diabetes mellitus status. Po.05 was considered to be
statistically significant. All analyses were performed using
SPSS 11.0 statistical package for Windows 2000 (SPSS Inc.,
Chicago, IL).
RESULTS
The baseline characteristics of the 5,064 subjects are shown
in Table 1. Thirty-eight percent of the subjects were men,
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and the mean age was 68. Of the 5,064 subjects in this
study, 901 (17.8%) had orthostatic hypotension; the prev-
alence of orthostatic hypotension was higher in women
than in men (Po.001). Subjects with orthostatic hypoten-
sion were older (Po.001) and more likely to use antihy-
pertensive medication (Po.001) and had a higher BMI
(P5.04), higher systolic blood pressure (Po.001), and
higher prevalence of diabetes mellitus (P5.002). During
follow-up 668 had subjects CHD (mean follow-up period
6.0  3.5 years), 503 subjects had a stroke (mean follow-up
period 6.7  3.6 years), 571 subjects developed heart fail-
ure (mean follow-up period 6.6  3.9 years), and 1,835
subjects died (mean follow-up period 7.8  3.8 years). Of
the 901 subjects with orthostatic hypotension at baseline,
152 had CHD, 119 had stroke, 140 had heart failure, and
465 died during follow-up. In models adjusted for age and
sex, orthostatic hypotension predicted CHD (HR5 1.31,
95% CI51.08–1.57), heart failure (HR51.21, 95% CI5
1.00–1.48), and all-cause mortality (HR5 1.22, 95%
CI51.09–1.36) (Table 2). The association between ortho-
static hypotension and heart failure was less consistent in
models adjusted for cardiovascular risk factors. Stratified
analyses were performed to determine whether the associ-
ation between orthostatic hypotension and incident events
varied according to age, sex, hypertension status, and
diabetes mellitus status. Mean age was 59.3 (range 55–63)
in the first tertile, 67.0 (range 63.1–71.3) in the second ter-
tile, and 78.0 (range 71.4–98.7) in the third tertile. Hyper-
tension was present in 57.6% and diabetes mellitus in 8.9%
of the participants. In the younger subjects (first tertile),
orthostatic hypotension predicted all-cause mortality
(HR51.80, 95% CI51.25–2.60) and showed a trend
for CHD (HR51.56, 95% CI50.99–2.46). In the older
subjects (third tertile), orthostatic hypotension predicted
stroke (HR51.35, 95% CI51.04–1.75), heart failure
(HR51.32, 95% CI5 1.04–1.67), and all-cause mortality
(HR51.27, 95% CI51.11–1.44) (Table 3). In hyperten-
sive participants, orthostatic hypotension increased the risk
of CHD (HR51.27, 95% CI51.03–1.57) and all-cause
mortality (HR51.20, 95% CI51.06–1.36). In subjects
with diabetes mellitus, orthostatic hypotension doubled the
risk of heart failure (HR51.97, 95% CI51.22–3.19).
DISCUSSION
In the present study, orthostatic hypotension slightly
increased the risk of CHD and all-cause mortality in appar-
ently healthy elderly people. Associations between ortho-
static hypotension and cardiovascular risk were strongest in
the younger and very old participants.
Previous studies have investigated the relationship be-
tween orthostatic hypotension and the risk of CHD, stroke,
Table 1. Baseline Characteristics of the Study Subjects (N5 5,064)
Characteristic
Total
(N55,064)
Subjects without
OH (n54,163)
Subjects with OH
(n5901) P-Value
Male, % 38.4 40.1 30.9 o.001
Age, mean  SD 68.1  8.5 67.3  8.2 71.8  8.8 o.001
Smoking, %
Current 22.4 22.3 23 .67
Former 41.6 42.6 37 .002
Never 36.0 35.1 40 .005
Antihypertensive medication, % 26.9 25.3 34.3 o.001
Body mass index, kg/m2, mean  SD 26.2  3.6 26.2  3.5 26.5  4.0 .04
Systolic blood pressure, mmHg, mean  SD 139  22 138  22 144  23 o.001
Diastolic blood pressure, mmHg, mean  SD 74  11 74  11 74  12 .94
Diabetes mellitus, % 8.9 8.3 11.5 .002
Total cholesterol, mmol/L, mean  SD 6.66  1.22 6.65  1.20 6.69  1.33 .35
High-density lipoprotein cholesterol, mmol/L, mean  SD 1.37  0.38 1.37  0.37 1.35  0.40 .08
Test of difference between means was performed using the Student t-test, and test of differences between proportions was performed using the chi-square test.
SD5 standard deviation; OH5 orthostatic hypotension.
Table 2. Cox Proportional Hazards Regression Models of Orthostatic Hypotension and Risk of Coronary Heart Dis-
ease (CHD), Stroke, Heart Failure, and All-Cause Mortality
Model
CHD (668/5,064) Stroke (503/5,064) Heart Failure (571/5,064) All-Cause Mortality (1,835/5,064)
Hazard Ratio (95% Confidence Interval) P-Value
1 1.31 (1.08–1.57) .005 1.17 (0.95–1.45) .13 1.21 (1.00–1.48) .05 1.22 (1.09–1.36) o.001
2 1.20 (1.00–1.45) .05 1.10 (0.89–1.36) .35 1.12 (0.92–1.36) .27 1.16 (1.04–1.29) .007
Model 1 adjusted for age and sex.
Model 2 adjusted for age, sex, smoking, use of antihypertensive medication, body mass index, systolic blood pressure, diastolic blood pressure, diabetes mellitus,
total cholesterol, and high-density lipoprotein cholesterol.
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and mortality. The Atherosclerosis Risk in Communities
Study, a large population-based prospective cohort study of
middle-aged participants (aged 45–65), found strong asso-
ciations between orthostatic hypotension and stroke,9
CHD,10 and mortality.11 Other studies have been per-
formed in the older subjects. The Honolulu Heart Pro-
gram,17 a prospective study of 3,741 Japanese men aged 71
to 93, found that orthostatic hypotension increased the risk
of all-cause mortality in elderly Japanese men. Other au-
thors have shown that orthostatic hypotension increased
the risk of MI and cardiovascular death in 700 home-
dwelling Finnish people aged 70 and older.12,14 On the
contrary, in studies of 500 acute geriatric ward patients15
and 350 subjects aged 65 and older,3 orthostatic hypoten-
sion did not increase the risk of vascular death.
As previously reported, also in this large population-
based study, orthostatic hypotension increased the risk of
CVD and all-cause mortality in elderly people. According to
previous studies,10,18,26 subjects with orthostatic hypoten-
sion were older, used antihypertensive medication more of-
ten, had a higher mean BMI and higher mean levels of
systolic blood pressure, andmore often had diabetesmellitus.
The association between orthostatic hypotension and
CVD may have several explanations. Orthostatic challenge
displaces blood to the lower body. This could decrease tho-
racic blood volume 25% to 30%.27 The secondary reduc-
tion in coronary and cerebral flow during a strong postural
blood pressure drop may cause myocardial and cerebral
ischemia.3 Orthostatic hypotension could also be the ex-
pression of underlying CVD. Cerebral infarcts, MIs, and
heart failure28,29 could cause orthostatic hypotension.3
Also, diabetes mellitus30 and hypertension10 may be asso-
ciated with orthostatic hypotension. Therefore, one possi-
ble question could be whether these conditions might
explain the association between orthostatic hypotension
andCVD. For this reason, subjects with previous CVDwere
excluded at baseline, and analyses adjusted for diabetes
mellitus, hypertension, and other cardiovascular risk fac-
tors were performed. Nevertheless, associations between
orthostatic hypotension and CHD and all-cause mortality
remained statistically significant after adjustments, suggest-
ing an independent prognostic role of orthostatic hypoten-
sion. The predictive role of orthostatic hypotension was
strongest in younger and very old subjects. Some studies
have suggested that orthostatic hypotension is a marker of
frailty in the very old,17 whereas the prevalence of ortho-
static hypotension is much lower in younger subjects.
Therefore, it might be speculated that the presence of
orthostatic hypotension in younger adults might be the
expression of an underlying silent CVD.
It is known that hypertension is associated with ortho-
static hypotension,4,26 particularly in elderly people, and
that both might be the expression of blood pressure dys-
function; the present study found that, in hypertensive sub-
jects, orthostatic hypotension increased the risk of CHD
and all-cause mortality.
The present study has some limitations. First, blood
pressure measurements were performed once, which could
bias the results because of the daily variability of blood
pressure. The use of multiple blood pressure measurements
might have improved accuracy and precision. Second, mea-
sures of orthostatic hypotension and blood pressure were
not available for all participants, although this will not have
biased the results, because this was due almost entirely to
logistic reasons and was therefore random. Third, the
study subjects were Caucasian, so generalizability of the
results might be difficult. Fourth, there could be some re-
sidual confounding. Orthostatic hypotension increases
the risk of falls and consequent hip fractures, and these
are associated with a high mortality rate, but because
these variables were not adjusted for, this relationship
cannot be assessed. Finally, no correction for multiple com-
parisons was performed, although it is unlikely that this
biased the results.
Table 3. Stratified Proportional Hazard Models of Orthostatic Hypotension and Risk of Coronary Heart Disease,
Stroke, Heart Failure, and All-Cause Mortality
Variable
CHD Stroke Heart Failure All-Cause Mortality
Events/Subjects; Hazard Ratio (95% Confidence Interval)
Sex
Male 343/1,946; 1.18 (0.88–1.57) 198/1,946; 1.09 (0.76–1.58) 249/1,946; 0.95 (0.67–1.33) 802/1,946; 1.27 (1.07–1.51)
Female 325/3,118; 1.22 (0.95–1.56) 305/3,118; 1.10 (0.85–1.42) 322/3,118; 1.22 (0.96–1.56) 1,033/3,118; 1.10 (0.95–1.26)
Age tertile
1 154/1,688; 1.56 (0.99–2.46) 61/1,688; 1.56 (0.76–3.20) 64/1,688; 1.13 (0.53–2.41) 211/1,688; 1.80 (1.25–2.60)
2 230/1,689; 1.14 (0.81–1.62) 169/1,689; 0.76 (0.49–1.19) 183/1,689; 0.91 (0.61–1.37) 501/1,689; 1.13 (0.89–1.42)
3 284/1,687; 1.21 (0.94–1.57) 273/1,687; 1.35 (1.04–1.75) 324/1,687; 1.32 (1.04–1.67) 1,123/1,687; 1.27 (1.11–1.44)
Hypertension
No 198/2,146; 0.93 (0.61–1.40) 129/2,146; 0.90 (0.55–1.46) 126/2,146; 0.99 (0.61–1.60) 564/2,146; 1.05 (0.84–1.30)
Yes 470/2,918; 1.27 (1.03–1.57) 374/2,918; 1.14 (0.90–1.44) 445/2,918; 1.14 (0.92–1.42) 1,271/2,918; 1.20 (1.06–1.36)
Diabetes mellitus
No 576/4,615; 1.15 (0.94–1.41) 422/4,615; 1.16 (0.92–1.46) 485/4,615; 1.00 (0.80–1.24) 1,579/4,615; 1.15 (1.02–1.29)
Yes 92/449; 1.36 (0.84–2.21) 81/449; 0.91 (0.52–1.61) 86/449; 1.97 (1.22–3.19) 256/449; 1.29 (0.97–1.72)
Note: Adjusted for age, sex, smoking, use of antihypertensive medication, body mass index, systolic blood pressure, diastolic blood pressure, diabetes mellitus,
total cholesterol, and high-density lipoprotein cholesterol (when appropriate).
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In conclusion, orthostatic hypotension increases the
risk of CHD and all-cause mortality in apparently healthy
elderly subjects. These findings support the call11 to under-
stand the mechanisms responsible for cardiovascular
morbidity and mortality in subjects with orthostatic hypo-
tension. There is much evidence that orthostatic hypoten-
sion increases cardiovascular risk in elderly people.9–12,14,17
Future studies are needed to investigate whether identifica-
tion and treatment of orthostatic hypotension can improve
cardiovascular prognosis.
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